Cargando…

Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era

Background. Patients with nonvalvular atrial fibrillation (NVAF) have five times higher risk of stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication after assessing the CHA2DS2-VASc and HAS-BLED scores. However, in the real world, NVAF patients receive less ACO t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gheorghe, Gabriela Silvia, Hodorogea, Andreea Simona, Gheorghe, Andrei Cristian Dan, Popa, Dragoș Emanuel, Vulpe, Simona, Georgescu, Cristina, Bănică, Ruxandra, Florescu, Andrei Gorgian, Trușcă, Elena Cristiana, Eden, Omer, Ciobanu, Ana, Pârvu, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317193/ https://www.ncbi.nlm.nih.gov/pubmed/35885863 http://dx.doi.org/10.3390/healthcare10071333

Ejemplares similares

Diagnostic Pitfalls in a Man with Systemic Lupus Erythematous
por: Dan Gheorghe, Andrei Cristian, et al.
Publicado: (2019)

Medical management of symptomatic severe aortic stenosis in patients non-eligible for transcatheter aortic valve implantation
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2020)

Androgen Deprivation Therapy, Hypogonadism and Cardiovascular Toxicity in Men with Advanced Prostate Cancer
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2021)

Predictive factors for obtaining a correct therapeutic range using antivitamin K anticoagulants: a tertiary center experience of patient adherence to anticoagulant therapy
por: Jurcuţ, Ruxandra, et al.
Publicado: (2015)

Evolution of Electrocardiographic Repolarization Parameters During Antiandrogen Therapy in Patients with Prostate Cancer and Hypogonadism
por: Gheorghe, Andrei Cristian Dan, et al.
Publicado: (2020)

Sense of Coherence and Quality of Life in Patients Treated with Antivitamin K Oral Anticoagulants: A Cross-Sectional Study
por: Anguas-Gracia, Ana, et al.
Publicado: (2021)

Particular etiology in a case of peripheral tetraparesis
por: Gheorghe, Gabriela S., et al.
Publicado: (2019)

Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014)

Perspectives and Future Directions of Anticoagulant Therapy in Coronary Artery Disease Patients
por: Komiyama, Maki, et al.
Publicado: (2023)

Subclinical left ventricular dysfunction in men under androgen deprivation therapy for prostate cancer, revealed by speckle‐tracking‐derived parameters, repolarization, and myocardial injury markers
por: Gheorghe, Andrei C. D., et al.
Publicado: (2021)

Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation
por: Kyriakou, Elias, et al.
Publicado: (2018)

Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
por: Perreault, Sylvie, et al.
Publicado: (2019)

Cost Implications of Formulary Decisions on Oral Anticoagulants in Nonvalvular Atrial Fibrillation
por: Biskupiak, Joseph, et al.
Publicado: (2013)

Biosynthesis of a Thiamin Antivitamin in Clostridium botulinum
por: Cooper, Lisa E., et al.
Publicado: (2014)

Antivitamins B(12)—Some Inaugural Milestones
por: Kräutler, Bernhard
Publicado: (2020)

Oral Anticoagulation in Patients with Chronic Liver Disease
por: Costache, Raluca S., et al.
Publicado: (2023)

How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
por: Schaefer, Jordan K., et al.
Publicado: (2015)

Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation
por: Kim, Young Dae, et al.
Publicado: (2015)

The use status of anticoagulation drugs for inpatients with nonvalvular atrial fibrillation in Southwest China
por: Zheng, Huan Jie, et al.
Publicado: (2017)

Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study
por: Van Ganse, Eric, et al.
Publicado: (2020)

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
por: Deitelzweig, Steven, et al.
Publicado: (2019)

Current Anticoagulant Usage Patterns and Determinants in Korean Patients with Nonvalvular Atrial Fibrillation
por: Ha, Hyun Su, et al.
Publicado: (2020)

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
por: Lip, Gregory Y. H., et al.
Publicado: (2021)

Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer
por: Potter, Adam S., et al.
Publicado: (2022)

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
por: Simon, Tracey G., et al.
Publicado: (2023)

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants
por: Baker, Christine L., et al.
Publicado: (2019)

Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany
por: Krejczy, Martin, et al.
Publicado: (2015)

Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation
por: Chen, Nemin, et al.
Publicado: (2018)

Utilization of Anticoagulants in Nonvalvular Atrial Fibrillation Before and After Catheter Ablation at Shanghai, China
por: Tingting, Chen, et al.
Publicado: (2019)

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study
por: Lip, Gregory Y.H., et al.
Publicado: (2018)

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer
por: Deitelzweig, Steven, et al.
Publicado: (2021)

Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation
por: Rymer, Jennifer A., et al.
Publicado: (2023)

Impact of anemia on major bleeding in patients taking oral anticoagulants for nonvalvular atrial fibrillation
por: Kinjo, Norito, et al.
Publicado: (2023)

Thiamine and selected thiamine antivitamins — biological activity and methods of synthesis
por: Tylicki, Adam, et al.
Publicado: (2018)

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
por: Ment, Jerome
Publicado: (2015)

Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities
por: Dobesh, Paul P., et al.
Publicado: (2015)

Setting priorities in the health care sector – the case of oral anticoagulants in nonvalvular atrial fibrillation in Denmark
por: Poulsen, Peter Bo, et al.
Publicado: (2017)

The differences of atrial thrombus locations and variable response to anticoagulation in nonvalvular atrial fibrillation with ventricular cardiomyopathy
por: Zhang, Hao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ith7f9tgqihejd5ntsgk3r3ne6